Retatrutide vs Semaglutide vs Tirzepatide

This guide compares published clinical trial data for three GLP-1-class peptides. It is educational only and not a substitute for advice from a qualified healthcare professional. Sources are listed at the end.

If you've been researching weight-loss peptides, you've run into these three names — and probably found the comparisons confusing or full of hype. This page fixes that. We'll explain the real differences in plain language, back every number with the actual clinical trials, and use simple visuals so you can see how they compare, not just read about it.

Here's the one idea that makes everything else click: these three are best understood as three generations of the same scientific idea — using gut hormones to reduce appetite — with each generation adding one more hormone target than the last. Let's start there.

The Simple Version: Three Generations

All three peptides, retatrutide, semaglutide, and tirzepatide, copy natural gut hormones that tell your brain you're full and help control blood sugar. The difference between them is simply how many of these hormone systems each one activates. More targets generally means a stronger effect on appetite and metabolism — which is why the results climb with each generation.

That's the whole story in one picture: semaglutide hits one target, tirzepatide two, retatrutide three — and the average weight loss rises with each. Now let's look at exactly what those "targets" are.

How They Differ: The Three Targets (Visual)

There are three gut-hormone systems in play. Each peptide works on a different number of them. Think of each target as a different lever that affects hunger and metabolism — pulling more levers at once produces a bigger effect.

Weight Loss Compared (Chart)

Here's what most people came for: how much weight each one produced in its clinical trials. The numbers below are the average weight loss from each drug's key studies, at the higher doses.

The Only Direct Comparison (So Far)

One trial — called SURMOUNT-5 — put semaglutide and tirzepatide head-to-head in the same study, which is the fairest possible comparison. This is the gold-standard evidence, because everything except the drug was kept the same.

In this direct test, tirzepatide clearly out-performed semaglutide — about 20.2% versus 13.7% weight loss — and did so with a similar side-effect profile, meaning the extra results didn't come at the cost of feeling worse. There is not yet a head-to-head trial pitting retatrutide against the other two, so retatrutide's lead over tirzepatide, while consistent across separate studies, hasn't been confirmed in a single shared trial. That's an honest and important distinction.

Full Side-by-Side

Everything in one place. This table covers the dimensions people ask about most.

We have dedicated deep-dive guides for each: our semaglutide complete guide, tirzepatide complete guide, and retatrutide complete guide.

The Availability Divide (An Important One)

Efficacy isn't the only thing that matters — availability is a genuine practical divide, and it's easy to miss when you're dazzled by the weight-loss numbers.

Side Effects Compared

Good news first: all three share the same type of side effects, because they work in similar ways. The effects are overwhelmingly digestive — nausea most of all, plus constipation, diarrhea, and reduced appetite. For all three, these are usually worst early and after dose increases, and they ease as the body adjusts.

A few honest points on the differences:

• All three are GI-dominant. Nausea is the most common effect across the board, and slow, careful dose increases (titration) are the key to tolerating any of them.
• Retatrutide showed the highest rate of digestive side effects in its trials at the top doses — which makes sense, as it's the most potent. It also showed mild increases in heart rate worth noting.
• Tirzepatide achieved its greater weight loss with a side-effect profile similar to semaglutide in the head-to-head trial — the extra results didn't mean feeling proportionally worse.
• Muscle loss applies to all three. As with any major weight loss, some is lean muscle — so protein and resistance training matter regardless of which you consider.

For managing these, and the full safety picture, see our guides on common side effects, drug interactions, and when to consult a doctor.

Which One Is Right?

There's no single "best" — the right choice depends on what you prioritize. Here's an honest framing rather than a hard recommendation, since this is genuinely an individual decision that should involve a healthcare professional.

Common Questions

Important disclaimer: The information in this guide is general educational content only. It is not medical advice, a prescription, or a personalized recommendation. Weight-loss figures are averages from separate clinical trials (STEP 1, SURMOUNT-1, TRIUMPH-4, and the head-to-head SURMOUNT-5) with differing designs, doses, populations, and durations; individual results vary, and cross-trial figures are not a direct head-to-head comparison. Semaglutide and tirzepatide are FDA-approved medications when prescribed by a licensed clinician; retatrutide is investigational and not FDA-approved. Research-grade versions of these compounds are sold as research compounds intended for laboratory and scientific study, not as substitutes for prescribed, medically supervised treatment. This class of medication carries contraindications (including in people with a personal or family history of medullary thyroid carcinoma or MEN 2) and important drug interactions. Always consult a qualified healthcare professional before beginning any peptide protocol. Products sold by Peptides Costa Rica are intended for laboratory and research purposes only.